The first objective was to evaluate the efficacy on the vaccine compared to placebo in lessening cocaine use. Secondary targets incorporated confirming vaccine immunogenicity by means of IgG anti-cocaine antibody stages and analyzing the safety and tolerability of vaccination by way of a twenty 7 days study and at 24 https://emmap741bxt6.webdesign96.com/profile